Baxter International Inc. (BAX): Price and Financial Metrics
Baxter International Inc. (BAX)
Today's Latest Price: $81.09 USD
Updated Oct 23 7:00pm
Add BAX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 142 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
BAX Stock Summary
- Baxter International Inc's market capitalization of $41,379,381,774 is ahead of 95.16% of US-listed equities.
- BAX's went public 34.83 years ago, making it older than 92.9% of listed US stocks we're tracking.
- In terms of volatility of its share price, BAX is more volatile than only 0.61% of stocks we're observing.
- Stocks with similar financial metrics, market capitalization, and price volatility to Baxter International Inc are A, RMD, EBAY, ETN, and PHG.
- Visit BAX's SEC page to see the company's official filings. To visit the company's web site, go to www.baxter.com.
BAX Stock Price Chart Interactive Chart >
BAX Price/Volume Stats
| Current price | $81.09 | 52-week high | $95.19 |
| Prev. close | $81.45 | 52-week low | $69.10 |
| Day low | $80.84 | Volume | 1,676,967 |
| Day high | $81.93 | Avg. volume | 3,088,427 |
| 50-day MA | $81.86 | Dividend yield | 1.2% |
| 200-day MA | $85.37 | Market Cap | 41.05B |
Baxter International Inc. (BAX) Company Bio
Baxter International provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition, biosurgery products and anesthetics, and pharmacy automation, software and services. The company was founded in 1931 and is based in Deerfield, Illinois.
BAX Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $81.09 | $26.42 | -68% |
We started the process of determining a valid price forecast for Baxter International Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Baxter International Inc ranked in the 22th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Baxter International Inc, consider:
- BAX's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 29.2% of tickers in our DCF set.
- Baxter International Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.
- The weighted average cost of capital for the company is 8. This value is greater than only 21.45% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -68% |
| 1% | -68% |
| 2% | -68% |
| 3% | -67% |
| 4% | -67% |
| 5% | -67% |
Want more companies with a valuation profile/forecast similar to that of Baxter International Inc? See ABT, GMED, MDT, OFIX, and SRDX.
Loading social stream, please wait...